BioNTech
phase trial favorable safety profile and encouraging signs of efficacy for car cells aes with with with symptoms clinical activity | BioNTech
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
25 of 40
Related slides by other companies
Vincera
SPAC
September 2020
early signs of efficacy in phase with | Vincera
CG Oncology
IPO
March 2024
phase study for high risk exposed and naive planned study | CG Oncology
Genelux
Investor Presentation
July 2023
phase anti tumor activity as leading into combination platinum resistant | Genelux
Myovant Sciences
Results
August 2022
phase spirit clinical program | Myovant Sciences
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io